Clear Harbor Asset Management, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Clear Harbor Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$2.97 - $3.83 $445 - $574	-150 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$2.97 - $5.08 $445 - $762	150 New	150 $0
Q1 2020 May 08, 2020	SELL	$2.61 - $5.21 $261 - $521	-100 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$3.67 - $5.7 $367 - $570	100 New	100 $0
Q1 2019 Apr 19, 2019	SELL	$2.11 - $5.33 $35,764 - $90,343	-16,950 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$2.81 - $3.78 $14,050 - $18,900	-5,000 Reduced 22.78%	16,950 $54,000
Q2 2018 Aug 03, 2018	BUY	$2.26 - $3.84 $24,068 - $40,896	10,650 Added 94.25%	21,950 $68,000
Q1 2018 May 01, 2018	BUY	$2.39 - $4.01 $27,007 - $45,313	11,300 New	11,300 $27,000

326

94M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.15B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.